154 related articles for article (PubMed ID: 326046)
1. Amikacin therapy of patients with multiply antibiotic-resistant Serratia marcescens infections: development of increasing resistance during therapy.
Craven PC; Jorgensen JH; Kaspar RL; Drutz DJ
Am J Med; 1977 Jun; 62(6):902-10. PubMed ID: 326046
[TBL] [Abstract][Full Text] [Related]
2. Gentamicin-resistant bacillary infection. Clinical features and amikacin therapy.
Leonard JM; McGee ZA; Alford RH
Arch Intern Med; 1978 Feb; 138(2):201-5. PubMed ID: 415674
[TBL] [Abstract][Full Text] [Related]
3. Clinical, epidemiologic and microbiologic features of a persistent outbreak of amikacin-resistant Serratia marcescens.
Arroyo JC; Milligan WL; Postic B; Northey J; Parker E; Bryan CS
Infect Control; 1981; 2(5):367-72. PubMed ID: 7028654
[TBL] [Abstract][Full Text] [Related]
4. Clinical efficacy of a synergistic combination of cefotaxime and amikacin against multiresistant Pseudomonas and Serratia infections.
Maslow MJ; Simberkoff MS; Rahal JJ
J Antimicrob Chemother; 1985 Aug; 16(2):227-34. PubMed ID: 3934125
[TBL] [Abstract][Full Text] [Related]
5. Gentamicin-resistant Serratia marcescens endophthalmitis.
Gammon JA; Schwab I; Joseph P
Arch Ophthalmol; 1980 Jul; 98(7):1221-3. PubMed ID: 6994702
[TBL] [Abstract][Full Text] [Related]
6. Outbreak of amikacin-resistant Enterobacteriaceae in an intensive care nursery.
Cook LN; Davis RS; Stover BH
Pediatrics; 1980 Feb; 65(2):264-8. PubMed ID: 6986597
[TBL] [Abstract][Full Text] [Related]
7. Amikacin treatment of Serratia septicemia in critically ill patients.
Mosquera JM; de Villota ED; de la Serna JL; Diez-Balda V; Tomás MI; Galdos P; Rubio JJ
Crit Care Med; 1981 Sep; 9(9):633-6. PubMed ID: 7023839
[TBL] [Abstract][Full Text] [Related]
8. Amikacin therapy of gram-negative bacteremia and meningitis. Treatment in diseases due to multiple resistant bacilli.
Sklaver AR; Greenman RL; Hoffman TA
Arch Intern Med; 1978 May; 138(5):713-6. PubMed ID: 348135
[TBL] [Abstract][Full Text] [Related]
9. [Clinico-bacteriological study of 20 Serratia marcescens infections treated with amikacin].
Pérez González F; Prendes Peláez P; Meana Fonseca JL; Martín Alvarez R
Rev Clin Esp; 1981 Jun 15-30; 161(5-6):327-34. PubMed ID: 7027369
[No Abstract] [Full Text] [Related]
10. Amikacin therapy. Use against infections caused by gentamicin- and tobramycin-resistant organisms.
Yu VL; Rhame FS; Pesanti EL; Axline SG
JAMA; 1977 Aug; 238(9):943-7. PubMed ID: 328950
[TBL] [Abstract][Full Text] [Related]
11. Infection with netilmicin resistant Serratia marcescens in a special care baby unit.
Lewis DA; Hawkey PM; WattsJA ; Speller DC; Primavesi RJ; Fleming PJ; Pitt TL
Br Med J (Clin Res Ed); 1983 Dec; 287(6406):1701-5. PubMed ID: 6315130
[TBL] [Abstract][Full Text] [Related]
12. [Fundamental and clinical studies on amikacin (BB-K8) in complicated urinary tract infections (author's transl)].
Mita T; Mayumi K; Kataoka N; Ishigami J
Jpn J Antibiot; 1977 Mar; 30(3):215-22. PubMed ID: 404447
[No Abstract] [Full Text] [Related]
13. Evidence for a chromosomal site specifying amikacin resistance in multiresistant Serratia marcescens.
John JF; McNeill WF; Price KE; Kresel PA
Antimicrob Agents Chemother; 1982 Apr; 21(4):587-91. PubMed ID: 7044303
[TBL] [Abstract][Full Text] [Related]
14. Loss of an aminoglycoside resistance plasmid by Serratia marcescens during treatment of meningitis with amikacin.
Rubens CE; McGee ZA; Farrar WE
J Infect Dis; 1980 Mar; 141(3):346-50. PubMed ID: 6988523
[TBL] [Abstract][Full Text] [Related]
15. Serratia marcescens bacteremia.
Wong WW; Wang LS; Cheng DL; Lin SJ; Chin TD; Hinthorn DR; O'Connor MC; Huang WK
J Formos Med Assoc; 1991 Jan; 90(1):88-93. PubMed ID: 1679115
[TBL] [Abstract][Full Text] [Related]
16. Amikacin therapy for severe gram-negative sepsis. Emphasis on infections with gentamicin-resistant organisms.
Tally FP; Louie TJ; Weinstein WM; Bartlett JG; Gorbach SL
Ann Intern Med; 1975 Oct; 83(4):484-8. PubMed ID: 1101761
[TBL] [Abstract][Full Text] [Related]
17. Treatment of hospita-acquired infections with amikacin.
Doughty SC; Martin RR; Greenberg SB
Am J Med; 1977 Jun; 62(6):889-93. PubMed ID: 868903
[TBL] [Abstract][Full Text] [Related]
18. [Treatment of hospital-acquired urinary infections with amikacin (author's transl)].
Weidner W; Nöske HD; Sziegoleit A; Schröder R; Leidenfrost U
Med Klin; 1979 Jul; 74(27):1071-6. PubMed ID: 470792
[TBL] [Abstract][Full Text] [Related]
19. Amikacin therapy for severe gram-negative sepsis: efficacy in infections involving gentamicin-resistant organisms.
Tally FP; Louie TJ; O'Keefe P; Gorbach SL; Bartlett JG
J Infect Dis; 1976 Nov; 134 SUPPL():S428-32. PubMed ID: 993634
[TBL] [Abstract][Full Text] [Related]
20. Patterns and mechanisms of emergence of resistance to amikacin.
Meyer RD
J Infect Dis; 1977 Sep; 136(3):449-52. PubMed ID: 409785
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
